Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_assertion type Assertion NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_head.
- NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_assertion wasGeneratedBy ECO_0000203 NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_provenance.
- NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_assertion wasDerivedFrom befree-20140225 NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_provenance.
- NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_assertion SIO_000772 21220007 NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_provenance.
- NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_assertion evidence source_evidence_literature NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_provenance.
- NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_assertion description "[A shRNA expression plasmid against human telomerase reverse transcriptase (hTERT) was constructed under the control of liver-specific promoter apolipoprotein A-I (ApoAI), designated as pApoAI-shTERT, and its liver-specific cytotoxicity and inhibition of telomerase activity were first evaluated in different cell lines, and its therapeutic effect was further studied in SMMC-7721 human liver tumor-bearing mice in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599311.RAlQdLL9L-T04bH9RIjCFRiFcYcwmmWuHe4uU3Kj4vmwo130_provenance.